Our rehab centers help men and women who are struggling with addictions, substance abuse and mental health disorders. We also provide treatment exclusively to International Association benzo withdrawal timeline of Fire Fighters (IAFF) members at our Maryland facility, the IAFF Center of Excellence for Behavioral Health Treatment and Recovery. Yes, medications like benzodiazepines (e.g., diazepam or lorazepam) are commonly used to manage withdrawal symptoms by reducing anxiety, seizures, and tremors.
Benzodiazepines are commonly prescribed for anxiety, insomnia, and seizures, while barbiturates, though also used for similar purposes, have become less common due to their higher risk of overdose and dependence. Dependence refers to a physical reliance on the drug, where the body adapts to its presence, and withdrawal symptoms occur when use is reduced or stopped. Addiction, on the other hand, is characterized by compulsive drug-seeking behavior and loss of control over usage despite negative consequences. Many providers across disciplines struggle with helping patients taper or even broaching the subject. One patient who has been taking BZDs for years may have little trouble tapering at a rate of 25% every 2-4 weeks. Another patient who drug addiction has been taking BZD for less time may experience significant and persistent withdrawal symptoms even with a much slower taper.
Dissociative drugs can temporarily alter a person’s mood, thoughts, and perceptions of reality. These drugs primarily affect how the brain processes a chemical called glutamate. Dissociative drugs can make people feel disconnected from their body and environment. Lofexidine is an FDA-approved medication to reduce opioid withdrawal symptoms. Any medical decision-making should rely on clinical judgment and independently verified information.

There are currently no FDA-approved medications to treat MDMA-related substance use disorders. https://ecosoberhouse.com/ There are currently no FDA-approved medications to treat a loperamide-related substance use disorder. There are currently no FDA-approved medications to treat ketamine use disorder. There are currently no FDA-approved medications to treat a substance use disorder related to GHB.

Common side effects include drowsiness, confusion, dizziness, blurred vision, and poor coordination. With prolonged use of benzodiazepines, individuals may experience memory problems, emotional blunting, slowed reaction times, and increased risk of depression. Long-term use can also lead to physical dependence and withdrawal symptoms if the drug is reduced or stopped suddenly.
Methadone, buprenorphine, and naltrexone are all FDA-approved medications to treat opioid use disorder. A few studies have suggested that ibogaine can reduce substance use withdrawal symptoms and cravings, but deaths have been reported in these studies and more research is needed. Hydrocodone is a prescription opioid medication approved by the FDA for pain management. For example, fentanyl can be added to counterfeit prescription pills or other illegal drugs.

Physical symptoms such as drowsiness, memory problems, and impaired coordination are also common. In severe cases, withdrawal symptoms occur when attempting to reduce or stop usage. In general, the optimal treatment of these conditions in primary care is non-pharmacological, particularly psychological and behavioural, therapies.